Literature DB >> 22341775

[Environmental tobacco smoke exposure in children and its relationship with the severity of asthma].

R G Suárez López de Vergara1, C Galván Fernández, C Oliva Hernández, A Aguirre-Jaime, A Aquirre-Jaime, C Vázquez Moncholí.   

Abstract

INTRODUCTION: Environmental tobacco smoke (ETS) exposure produces serious respiratory problems in childhood. The aim of the study was to evaluate if environmental tobacco smoke affects the severity of asthma in asthmatic children.
MATERIAL AND METHODS: A prospective, multicentre study was conducted on asthmatic children and their parents in 2007-2008, using an exposure questionnaire, pulmonary function, level of cotinine in urine, and evaluation of the severity of asthma according to GEMA guide. The characteristics of the sample are summarised using the appropriate statistical tools, and the comparisons were made using the Pearson chi2 test, Mann-Whitney U test or Studentĭs t, according to the variable and number of groups compared.
RESULTS: Four hundred and eighty four households in 7 Autonomous Communities were included. The population included, 61% male children with asthma, 56% with a smoking caregiver in their home, 34% fathers, 31% mothers and 17% both. Home exposure was 37%, with 11% daily and 94% passive smokers since birth. There was 20% with exposure during whole period of pregnancy of 5±1 cigarettes/day. Children exposed to 6±1 cigarettes/day, 27%, up to 10 cigarettes/day, and 10% to more than 10. Severity of asthma during the survey was worse among those exposed (episodic-occasional 47%, episodic-frequent 35% and persistent-moderate 18% versus 59%, 25% and 16%, respectively, P=.040). Severity of asthma in the last year was worse in those exposed (episodic - occasional 22%, episodic - frequent 37% and persistent - moderate 50% versus 38%, 28% and 25% respectively, P=.037). The spirometry was abnormal in 64% of the exposed against to 36% in the non-exposed for FEV(1) (P=.003, 63% vs 38% for FVC (P=.038), and 54% vs 46% for the PEF (P=.050). The cotinine was higher in exposed: 51 (0-524) ng/ml vs 27 (0-116) ng/ml (P=.032). A relationship was observed between cotinine and level of exposure: 120 (0-590) ng/ml for >10 cigarettes/day as opposed to 44 (0-103) ng/ml ≤10 cigarettes/day (P=.035), which corroborates the consistency of the data collected.
CONCLUSIONS: The exposure of children with asthma to environmental tobacco smoke has a highly negative effect on the severity of their asthma.
Copyright © 2011 Asociación Española de Pediatría. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341775     DOI: 10.1016/j.anpedi.2011.12.008

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  5 in total

1.  Passive smoking could still represent a risk factor in Mexican children with asthma.

Authors:  Aranza Pinedo Pichilingue; Javier Quijano Ono
Journal:  Asia Pac Allergy       Date:  2013-04

2.  Lack of association between passive smoking and asthma prevalence in Mexican children.

Authors:  Martín Bedolla-Barajas; Jaime Morales-Romero
Journal:  Asia Pac Allergy       Date:  2013-04

3.  [Factors associated with asthma in children and adolescents in rural areas of Navarre (Spain)].

Authors:  Itsaso Elizalde-Beiras; Francisco Guillén-Grima; Inés Aguinaga-Ontoso
Journal:  Aten Primaria       Date:  2017-09-19       Impact factor: 1.137

4.  Effects of outdoor and indoor air pollution on respiratory health of Chinese children from 50 kindergartens.

Authors:  Miao-Miao Liu; Da Wang; Yang Zhao; Yu-Qin Liu; Mei-Meng Huang; Yang Liu; Jing Sun; Wan-Hui Ren; Ya-Dong Zhao; Qin-Cheng He; Guang-Hui Dong
Journal:  J Epidemiol       Date:  2013-06-01       Impact factor: 3.211

5.  [ETAP: A smoking scale for Primary Health Care].

Authors:  Pilar María González Romero; Francisco Javier Cuevas Fernández; Itahisa Marcelino Rodríguez; María Del Cristo Rodríguez Pérez; Antonio Cabrera de León; Armando Aguirre-Jaime
Journal:  Aten Primaria       Date:  2015-10-09       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.